Ruxolitinib is an effective steroid sparing agent in children with steroid refractory/dependent bronchiolitis obliterans syndrome after allogenic hematopoietic cell transplantation

Authors:

Abstract
No abstract available

This publication has 10 references indexed in Scilit: